Threat of Staphylococcus aureus Pneumonia in Severe COVID-19 Patients

  • Tanaka S
  • Yamamoto K
  • Hagiya H
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) has been spreading worldwide with unprecedented rapidity. Staphylococcus aureus is reported to frequently cause bacterial complications in patients with COVID-19. We herein present two additional cases of S. aureus pneumonia involving such patients. The first case was an obese 48-year-old man without any particular underlying diseases. The second case was another patient, a 72-year-old man, with hypertension, dyslipidemia, and steatohepatitis. Both patients developed methicillin-susceptible S. aureus pneumonia in the clinical course of COVID-19, to which antibiotic therapy with cefazolin was effectively administered. Through these cases, we emphasize that S. aureus secondary infections should be well cared with a high degree of caution in a case of critically ill COVID-19 patients.

Cite

CITATION STYLE

APA

Tanaka, S., Yamamoto, K., Hagiya, H., Hasegawa, K., & Otsuka, F. (2022). Threat of Staphylococcus aureus Pneumonia in Severe COVID-19 Patients. Cureus. https://doi.org/10.7759/cureus.22486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free